Adam Forsyth

Alto Neuroscience stock rises as firm secures $120M to advance depression drug

Alto Neuroscience, a clinical-stage biopharmaceutical company focused on neuropsychiatric disorders, has secured $120 million from institutional and accredited investors to advance ALTO-207, a fixed-dose combination targeting treatment-resistant depression. ALTO-207 is a novel therapy for treatment-resistant depression that pairs pramipexole, a dopamine receptor agonist, with ondansetron. The combination is designed to enhance antidepressant effects in patients…

Read More

Ethereum Price $2,200 Recovery: Reversal Confirmed?

Ethereum price has finally begun to recover, climbing back above the psychologically significant $2,150 zone after weeks of testing holders’ patience. As usual, the requirements are the same: ETH must close the daily candle above $2,200 and hold this level to potentially build a further upward leg (with $2,500-2,700 as immediate targets). However, breaking below…

Read More

Tesla secures SpaceX stake through xAI merger ahead of IPO

Tesla has received regulatory clearance to convert its investment in Elon Musk’s artificial intelligence firm xAI into a small stake in SpaceX, formalizing financial ties between the billionaire’s companies ahead of the rocket maker’s planned initial public offering, according to a Bloomberg report. Filings with the US Federal Trade Commission list Tesla as the acquirer…

Read More

BlockFills files for Chapter 11 bankruptcy after suspending withdrawals and deposits

Crypto trading platform BlockFills announced today that it has entered Chapter 11 after the company suspended trading and withdrawals amid market volatility. The decision follows extensive discussions with investors, clients, creditors, and other stakeholders and is intended to preserve the value of the business while maximizing recoveries, according to the firm. Following our previous communication…

Read More